Literature DB >> 15144330

External cephalic version: a safe procedure? A systematic review of version-related risks.

Ronald J Collaris1, S Guid Oei.   

Abstract

BACKGROUND: The Term Breech Trial has considerably increased the number of cesareans. External cephalic version (ECV) might be an effective method of lowering the rate of cesareans; its efficacy has been well established. However, although in the absence of anesthesia the risks are thought to be low, most studies have used populations too small to allow definite conclusions on version-related risks.
METHODS: In an attempt to make an inventory of these risks, we have systematically analyzed 44 studies, covering a total of 7377 patients from 1990 to 2002. The studies used were derived from a Medline and Embase search.
RESULTS: The most frequently reported complications were transient abnormal cardiotocography (CTG) patterns (5.7%). Persisting pathological CTG readings (0.37%) and vaginal bleeding occur rarely (0.47%). The incidence of placental abruption was even lower, at 0.12%. Fetomaternal transfusion was absent in five out of seven studies, with a mean incidence of 3.7%. Emergency cesareans were performed in 0.43% of all versions. Perinatal mortality was 0.16%.
CONCLUSIONS: External cephalic version seems to be a safe procedure.

Entities:  

Mesh:

Year:  2004        PMID: 15144330     DOI: 10.1111/j.0001-6349.2004.00347.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  14 in total

1.  Utilization of epidural volume extension technique for external cephalic version.

Authors:  Hanna Hussey; James Damron; Mark F Powell; Michelle Tubinis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-02-02

2.  Association Between Attempted External Cephalic Version and Perinatal Morbidity and Mortality.

Authors:  Moeun Son; Archana Roy; William A Grobman; Emily S Miller
Journal:  Obstet Gynecol       Date:  2018-08       Impact factor: 7.661

Review 3.  External cephalic version for breech presentation at term.

Authors:  G Justus Hofmeyr; Regina Kulier; Helen M West
Journal:  Cochrane Database Syst Rev       Date:  2015-04-01

4.  The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies.

Authors:  E K Hutton; M E Hannah; S J Ross; M-F Delisle; G D Carson; R Windrim; A Ohlsson; A R Willan; A Gafni; G Sylvestre; R Natale; Y Barrett; J K Pollard; M S Dunn; P Turtle
Journal:  BJOG       Date:  2011-02-04       Impact factor: 6.531

5.  The Effects of Clinical Hypnosis versus Neurolinguistic Programming (NLP) before External Cephalic Version (ECV): A Prospective Off-Centre Randomised, Double-Blind, Controlled Trial.

Authors:  Joscha Reinhard; Swati Peiffer; Nicole Sänger; Eva Herrmann; Juping Yuan; Frank Louwen
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-21       Impact factor: 2.629

6.  Coming out ahead: the cost effectiveness of external cephalic version using spinal anesthesia.

Authors:  James A O'Brien; Eli Y Adashi
Journal:  Isr J Health Policy Res       Date:  2014-02-24

Review 7.  Improving external cephalic version for foetal breech presentation.

Authors:  H Zandstra; H J M M Mertens
Journal:  Facts Views Vis Obgyn       Date:  2013

8.  Cost-effectiveness of external cephalic version for term breech presentation.

Authors:  Jonathan M Tan; Alex Macario; Brendan Carvalho; Maurice L Druzin; Yasser Y El-Sayed
Journal:  BMC Pregnancy Childbirth       Date:  2010-01-21       Impact factor: 3.007

9.  Successful external cephalic version: factors predicting vaginal birth.

Authors:  Pei Shan Lim; Beng Kwang Ng; Anizah Ali; Mohamad Nasir Shafiee; Nirmala Chandralega Kampan; Nor Azlin Mohamed Ismail; Mohd Hashim Omar; Zaleha Abdullah Mahdy
Journal:  ScientificWorldJournal       Date:  2014-01-22

10.  A randomized trial of remifentanil for analgesia in external cephalic version for breech presentation.

Authors:  Xiaohua Liu; Aiqin Xue
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.